中文产业新闻评分62Chinese source
海和药物紫杉醇口服溶液（柏瑞素®）获NMPA批准，用于复发性或转移性HER2阴性乳腺癌
刚刚，「紫杉醇口服溶液」乳腺癌适应症获批上市
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
刚刚，「紫杉醇口服溶液」乳腺癌适应症获批上市
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.